Oxaliplatin induces hypomyelination and reduced neuregulin 1 expression in the rat sciatic nerve

Neuroscience Research

Volumn 80, Issue 1, 2014, Pages 86-90

  Tsutsumi, Kuniaki ^a   Yamashita, Yuji ^a   Ushio, Soichiro ^a   Kawashiri, Takehiro ^a   Kaname, Takanori ^a   Fujita, Shunsuke ^a   Oishi, Ryozo ^a   Egashira, Nobuaki ^a  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Hypomyelination; Myelin protein zero; Neuregulin; Neuropathy; Oxaliplatin

Indexed keywords

ANTINEOPLASTIC AGENT; MESSENGER RNA; MYELIN PROTEIN; NEU DIFFERENTIATION FACTOR; OXALIPLATIN; PLATINUM COMPLEX;

ANIMAL; CHEMICALLY INDUCED; DNA MICROARRAY; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; NERVE FIBER; PATHOLOGY; POLYRADICULONEUROPATHY; RAT; SCIATIC NERVE; SPINAL GANGLION; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; ANTINEOPLASTIC AGENTS; AXONS; GANGLIA, SPINAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MALE; MYELIN PROTEINS; NEUREGULIN-1; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGANOPLATINUM COMPOUNDS; POLYRADICULONEUROPATHY; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SCIATIC NERVE; TIME FACTORS;

EID: 84898814744     PISSN: 01680102     EISSN: 18728111     Source Type: Journal    
DOI: 10.1016/j.neures.2014.02.004     Document Type: Article

References (27)

1. Abramoff M.D., Magelhaes P.J., Ram S.J. Image processing with image. J. Biophotonics Int. 2004, 11:36-42.
2. Cassidy J., Misset J.L. Oxaliplatin-related side effects: characteristics and management. Semin. Oncol. 2002, 29:11-20.
3. Cavaletti G., Tredici G., Petruccioli M.G., Donde E., Tredici P., Marmiroli P., Minoia C., Ronchi A., Bayssas M., Etienne G.G. Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat. Eur. J. Cancer 2001, 37:2457-2463.
4. Chen S., Velardez M.O., Warot X., Yu Z.X., Miller S.J., Cros D., Corfas G. Neuregulin 1-erbB signaling is necessary for normal myelination and sensory function. J. Neurosci. 2006, 26:3079-3086.
5. Extra J.M., Marty M., Brienza S., Misset J.L. Pharmacokinetics and safety profile of oxaliplatin. Semin. Oncol. 1998, 25:13-22.
6. Falls D.L. Neuregulins: functions, forms, and signaling strategies. Exp. Cell Res. 2003, 284:14-30.
7. Frensing T., Kaltschmidt C., Schmitt-John T. Characterization of a neuregulin-1 gene promoter: positive regulation of type I isoforms by NF-kappaB. Biochim. Biophys. Acta 2008, 1779:139-144.
8. Gautron M., Jazat F., Ratinahirana H., Hauw J.J., Guilbaud G. Alterations in myelinated fibres in the sciatic nerve of rats after constriction: possible relationships between the presence of abnormal small myelinated fibres and pain-related behaviour. Neurosci. Lett. 1990, 111:28-33.
9. Hu X., Hicks C.W., He W., Wong P., Macklin W.B., Trapp B.D., Yan R. BACE1 modulates myelination in the central and peripheral nervous system. Nat. Neurosci. 2006, 9:1520-1525.
10. Inoue M., Rashid M.H., Fujita R., Contos J.J., Chun J., Ueda H. Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nat. Med. 2004, 10:712-718.
11. Juretic N., Jorquera G., Caviedes P., Jaimovich E., Riveros N. Electrical stimulation induces calcium-dependent up-regulation of neuregulin-1β in dystrophic skeletal muscle cell lines. Clin. Physiol. Biochem. 2012, 29:919-930.
12. Kao S.C., Wu H., Xie J., Chang C.P., Ranish J.A., Graef I.A., Crabtree G.R. Calcineurin/NFAT signaling is required for neuregulin-regulated Schwann cell differentiation. Science 2009, 323:651-654.
13. Kawashiri T., Egashira N., Watanabe H., Ikegami Y., Hirakawa S., Mihara Y., Yano T., Ikesue H., Oishi R. Prevention of oxaliplatin-induced mechanical allodynia and neurodegeneration by neurotropin in the rat model. Eur. J. Pain 2011, 15:344-350.
14. Kiryu-Seo S., Ohno N., Kidd G.J., Komuro H., Trapp B.D. Demyelination increases axonal stationary mitochondrial size and the speed of axonal mitochondrial transport. J. Neurosci. 2010, 30:6658-6666.
15. Luo X., Prior M., He W., Hu X., Tang X., Shen W., Yadav S., Kiryu-Seo S., Miller R., Trapp B.D., Yan R. Cleavage of neuregulin-1 by BACE1 or ADAM10 protein produces differential effects on myelination. J. Biol. Chem. 2011, 286:23967-23974.
16. Michailov G.V., Sereda M.W., Brinkmann B.G., Fischer T.M., Haug B., Birchmeier C., Role L., Lai C., Schwab M.H., Nave K.A. Axonal neuregulin-1 regulates myelin sheath thickness. Science 2004, 304:700-703.
17. Mihara Y., Egashira N., Sada H., Kawashiri T., Ushio S., Yano T., Ikesue H., Oishi R. Involvement of spinal NR2B-containing NMDA receptors in oxaliplatin-induced mechanical allodynia in rats. Mol. Pain 2011, 7:8.
18. Newbern J., Birchmeier C. Nrg1/ErbB signaling networks in Schwann cell development and myelination. Semin. Cell Dev. Biol. 2010, 21:922-928.
19. Ohno M., Hiraoka Y., Matsuoka T., Tomimoto H., Takao K., Miyakawa T., Oshima N., Kiyonari H., Kimura T., Kita T., Nishi E. Nardilysin regulates axonal maturation and myelination in the central and peripheral nervous system. Nat. Neurosci. 2009, 12:1506-1513.
20. Pasetto L.M., D'Andrea M.R., Rossi E., Monfardini S. Oxaliplatin-related neurotoxicity: how and why?. Crit. Rev. Oncol. Hematol. 2006, 59:159-168.
21. Quasthoff S., Hartung H.P. Chemotherapy-induced peripheral neuropathy. J. Neurol. 2002, 249:9-17.
22. Renn C.L., Carozzi V.A., Rhee P., Gallop D., Dorsey S.G., Cavaletti G. Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice. Mol. Pain 2011, 7:29.
23. Sakurai M., Egashira N., Kawashiri T., Yano T., Ikesue H., Oishi R. Oxaliplatin-induced neuropathy in the rat: involvement of oxalate in cold hyperalgesia but not mechanical allodynia. Pain 2009, 147:165-174.
24. Sevilla T., Lupo V., Sivera R., Marco-Marin C., Martínez-Rubio D., Rivas E., Hernandez A., Palau F., Espinos C. Congenital hypomyelinating neuropathy due to a novel MPZ mutation. J. Peripher. Nerv. Syst. 2011, 16:347-352.
25. 2+/calmodulin-dependent protein kinase II reverses oxaliplatin-induced mechanical allodynia in rats. Mol. Pain 2012, 8:26.
26. Taveggia C., Zanazzi G., Petrylak A., Yano H., Rosenbluth J., Einheber S., Xu X., Esper R.M., Loeb J.A., Shrager P., Chao M.V., Falls D.L., Role L., Salzer J.L. Neuregulin-1 type III determines the ensheathment fate of axons. Neuron 2005, 47:681-694.
27. Yamauchi J., Chan J.R., Shooter E.M. Neurotrophin 3 activation of TrkC induces Schwann cell migration through the c-Jun N-terminal kinase pathway. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:14421-14426.